why choose us

First received: August 04, 2023

Clinical Trial: Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Solid Tumors

Study Type: INTERVENTIONAL


Official Title: An Open-label, Dose-escalation and Dose-finding, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 as Combination Therapy in Patients With Advanced Solid Tumors

Brief Summary: To evaluate the safety and tolerability of the combination therapy of KN510 and KN713 and determine the MTD and RP2D in patients with advanced solid tumors.

Read more